Bone Marrow Aspirate Morphology in UAE | Accurate Hematologic Cancer Diagnosis

Executive Summary & Core Metrics

Diagnostic Accuracy: 99.9% Sensitivity via ISO-Accredited Processing (ISO 9001:2015 Certified).
Collection Protocol: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
Clinical Guidance: Complimentary telephonic post-test consultation for result interpretation and hematology referral coordination.
Insurance & Billing: Direct billing verification available via WhatsApp +971 54 548 8731.

Test Overview & Methodology

Bone Marrow Aspirate Morphology is the gold-standard microscopic examination of bone marrow cellular architecture. It is essential for definitively diagnosing hematologic malignancies (leukemia, lymphoma, myeloma), unexplained cytopenias (anemia, neutropenia, thrombocytopenia), myelodysplastic syndromes, and metastatic marrow infiltration. The procedure provides direct, real-time insight into hematopoietic reserve and clonal cell populations.

Feature	Our: Bone Marrow Aspirate Morphology	Peripheral Blood Smear (Alternative)
Methodology	Light microscopy with Wright-Giemsa stain & cytochemistry	Peripheral blood smear light microscopy
Diagnostic Precision	High – directly assesses intramedullary production & clonality	Limited – reflects secondary, circulating changes only
Turnaround Time	1–2 Days	1 Day
Clinical Utility	Essential for staging, risk stratification & therapy monitoring	Screening tool; not definitive for marrow pathology

Physician Insight & Safety Protocols

“Bone marrow aspirate morphology provides the definitive cellular blueprint required to classify hematologic neoplasms. Correlation with flow cytometry and cytogenetics is non-negotiable for precision oncology protocols. A normal aspirate does not entirely exclude pathology, and abnormalities as subtle as dysplastic granulopoiesis warrant urgent hematology referral.”

— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology | DHA Registration ID: 61713011

Clinical Advisory & Pre-Procedure Medication Review

Patients are advised to disclose all prescribed and over-the-counter medications prior to aspiration. Antiplatelet agents (e.g., aspirin, clopidogrel) and anticoagulants (e.g., warfarin, apixaban) require structured peri-procedural management. Do not discontinue any prescribed medication without explicit guidance from your referring physician or hematologist.

Exclusion Criteria & Emergency Red Flags

Severe uncorrected coagulopathy: INR > 1.5 or platelet count < 20,000/µL requires correction before procedure.
Active soft tissue infection overlying the posterior iliac crest aspiration site.
Seek immediate medical attention if you experience fever (>38.5°C), severe local pain, uncontrolled bleeding, or expanding hematoma post-procedure.

Patient FAQ & Clinical Guidance

1. What is bone marrow aspirate morphology and why is it performed?

Bone marrow aspirate morphology evaluates the cellular composition and structure of the marrow to diagnose blood cancers (leukemia, lymphoma, myeloma), unexplained anemias, and marrow failure syndromes. It provides direct insight into hematopoietic health, guiding disease classification, staging, and treatment decisions.

2. How is the sample collected and what safety protocols are followed?

The aspiration is performed by a qualified specialist from the posterior iliac crest under strict sterile technique and local anesthesia. A thin needle extracts liquid marrow; patients typically feel pressure but minimal sharp pain. The entire procedure takes 15–20 minutes under continuous clinical monitoring. All samples are processed under ISO-accredited cold-chain logistics.

3. When will I get my results and how are they interpreted?

Results are available within 1 to 2 days. A complimentary telephonic consultation is provided to review the morphology report alongside your clinical history. Our specialist coordinates directly with your referring physician to ensure seamless integration into your care plan. Never interpret results independently; always review them with a qualified practitioner.

4. What are the risks and exclusion criteria for this procedure?

The procedure is low-risk when performed on appropriately selected patients. Exclusion criteria include severe uncorrected coagulopathy (INR > 1.5, platelets < 20,000/µL) and local infection at the puncture site. Post-procedure risks are rare but include minor local bleeding or discomfort. Immediate medical follow-up is advised for fever, severe pain, or swelling.

UAE Regulatory & Data Privacy Adherence

DNA Labs UAE strictly adheres to the Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical safety and patient consent protocols meet the standards defined by Federal Decree-Law No. 4 of 2016 on Medical Liability. Patients retain full rights to access, rectify, or request deletion of their personal health data in compliance with UAE data protection frameworks.

Clinical & Logistical Metadata

Test Name	Bone Marrow Aspirate Morphology
Price (AED)	1,800
Turnaround Time	1 – 2 Days
Sample Type / Matrix	Bone Marrow Aspirate
Methodology Used	Light Microscopy with Wright-Giemsa & Cytochemistry
ICD-10-CM Code	D75.9, Z01.89
LOINC Code	78185-9
DHA Facility License & Address	License No: 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE